Wave Life Sciences Ltd. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| GSK plc | — | Purchase | 1,470,000 | $19.00 | $27,930,000 | 18,245,691 | Dec 11, 2025 |
| Rawcliffe Adrian | — | Option Exercise | 42,000 | $5.97 | $250,740 | 54,700 | Dec 8, 2025 |
| Wagner Heidi L | — | Sale | 7,000 | $13.00 | $91,000 | 44,930 | Dec 8, 2025 |
| HENRY CHRISTIAN O | — | Sale | 6,445 | $12.75 | $82,174 | 12,700 | Dec 8, 2025 |
| Tan Aik Na | — | Sale | 7,494 | $15.00 | $112,410 | 25,400 | Dec 8, 2025 |
| Verdine Gregory L. | — | Sale | 7,980 | $14.05 | $112,119 | 275,217 | Dec 8, 2025 |
| Francis Chris | See Remarks | Option Exercise | 22,500 | $2.83 | $63,675 | 47,500 | Dec 8, 2025 |
| Moran Kyle | Chief Financial Officer | Sale | 50,000 | $18.00 | $900,000 | 89,218 | Dec 8, 2025 |
| CORRIGAN MARK | — | Sale | 6,515 | $14.07 | $91,666 | 28,815 | Dec 8, 2025 |
| Rawcliffe Adrian | — | Sale | 16,115 | $6.79 | $109,421 | 12,700 | Nov 13, 2025 |
| RA CAPITAL MANAGEMENT, L.P. | — | Purchase | 1,000 | $6.69 | $6,690 | 18,203,009 | Nov 13, 2025 |
| Verdine Gregory L. | — | Sale | 10,000 | $10.00 | $100,000 | 285,217 | Aug 22, 2025 |
| BOLNO PAUL | President and CEO | Sale | 217,351 | $10.10 | $2,195,245 | 121,000 | Aug 22, 2025 |
| Tan Aik Na | — | Option Exercise | 21,000 | $9.13 | $191,730 | 61,388 | Aug 15, 2025 |
| RA Capital Healthcare Fund LP | — | Award / Grant | 12,700 | — | — | 28,815 | Aug 11, 2025 |
| CORRIGAN MARK | — | Award / Grant | 12,700 | — | — | 44,930 | Aug 11, 2025 |
| Tan Aik Na | — | Award / Grant | 25,400 | — | — | 40,388 | Aug 11, 2025 |
| TAKANASHI KEN | — | Award / Grant | 12,700 | — | — | 5,729,003 | Aug 11, 2025 |
| Wagner Heidi L | — | Award / Grant | 12,700 | — | — | 44,930 | Aug 11, 2025 |
| HENRY CHRISTIAN O | — | Sale | 9,670 | $8.81 | $85,193 | 29,645 | Aug 11, 2025 |
| Rawcliffe Adrian | — | Award / Grant | 12,700 | — | — | 28,815 | Aug 11, 2025 |
| Verdine Gregory L. | — | Award / Grant | 12,700 | — | — | 295,217 | Aug 11, 2025 |
| TAKANASHI KEN | — | Sale | 4,872 | $8.75 | $42,630 | 5,716,303 | Aug 5, 2025 |
| Tan Aik Na | — | Sale | 1,127 | $8.75 | $9,861 | 14,988 | Aug 5, 2025 |
| Verdine Gregory L. | — | Sale | 30,000 | $6.95 | $208,500 | 282,517 | Jun 13, 2025 |
| HENRY CHRISTIAN O | — | Option Exercise | 10,500 | $9.13 | $95,865 | 26,615 | Mar 20, 2025 |
| BOLNO PAUL | President and CEO | Option Exercise | 169,025 | $2.48 | $419,182 | 507,376 | Mar 7, 2025 |
| Verdine Gregory L. | — | Option Exercise | 133,000 | $2.48 | $329,840 | 179,155 | Mar 7, 2025 |
| Vargeese Chandra | See Remarks | Option Exercise | 91,754 | $2.48 | $227,550 | 362,687 | Mar 4, 2025 |
| Moran Kyle | Chief Financial Officer | Award / Grant | 42,000 | — | — | 89,218 | Feb 4, 2025 |
| BOLNO PAUL | President and CEO | Award / Grant | 121,000 | — | — | 338,351 | Feb 4, 2025 |
| Vargeese Chandra | See Remarks | Award / Grant | 37,000 | — | — | 270,933 | Feb 4, 2025 |
| Francis Chris | See Remarks | Award / Grant | 25,000 | — | — | 25,000 | Feb 4, 2025 |
| Vargeese Chandra | See Remarks | Option Exercise | 46,000 | $2.48 | $114,080 | 233,933 | Jan 23, 2025 |
| BOLNO PAUL | President and CEO | Option Exercise | 50,000 | $2.48 | $124,000 | 267,351 | Nov 25, 2024 |
| BOLNO PAUL | President and CEO | Sale | 51,234 | $14.32 | $733,671 | 217,351 | Nov 15, 2024 |
| Francis Chris | See Remarks | Option Exercise | 36,000 | $8.17 | $294,120 | 36,000 | Nov 8, 2024 |
| Francis Chris | See Remarks | Sale | 22,500 | $13.50 | $303,750 | — | Oct 16, 2024 |
| BOLNO PAUL | President and CEO | Sale | 90,474 | $15.00 | $1,357,110 | 268,585 | Oct 16, 2024 |
| Moran Kyle | Chief Financial Officer | Option Exercise | 25,000 | $2.48 | $62,000 | 44,777 | Oct 11, 2024 |
| GSK plc | — | Purchase | 2,791,930 | $8.00 | $22,335,440 | 16,775,691 | Sep 27, 2024 |
| Moran Kyle | Chief Financial Officer | Sale | 17,146 | $9.00 | $154,314 | 19,777 | Sep 25, 2024 |
| BOLNO PAUL | President and CEO | Sale | 48,366 | $5.78 | $279,555 | 359,059 | Aug 21, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | — | Award / Grant | 16,115 | — | — | 16,115 | Aug 12, 2024 |
| Rawcliffe Adrian | — | Award / Grant | 16,115 | — | — | 16,115 | Aug 12, 2024 |
| Tan Aik Na | — | Award / Grant | 16,115 | — | — | 16,115 | Aug 12, 2024 |
| HENRY CHRISTIAN O | — | Award / Grant | 16,115 | — | — | 16,115 | Aug 12, 2024 |
| CORRIGAN MARK | — | Award / Grant | 32,230 | — | — | 32,230 | Aug 12, 2024 |
| Verdine Gregory L. | — | Award / Grant | 16,115 | — | — | 46,115 | Aug 12, 2024 |
| Wagner Heidi L | — | Award / Grant | 32,230 | — | — | 32,230 | Aug 12, 2024 |